Meinian Onehealth Healthcare Holdings Co.Ltd(002044) independent director
To the 9th meeting of the 8th board of directors of the company
Prior approval opinions on relevant matters
As an independent director of Meinian Onehealth Healthcare Holdings Co.Ltd(002044) (hereinafter referred to as “the company”), in accordance with the independent director rules of listed companies, the stock listing rules of Shenzhen Stock Exchange (revised in 2022), the self regulatory guidelines for listed companies of Shenzhen Stock Exchange No. 1 – standardized operation of companies listed on the main board, the governance standards of listed companies and other laws and regulations In accordance with the relevant provisions of the normative documents and the Meinian Onehealth Healthcare Holdings Co.Ltd(002044) articles of Association (hereinafter referred to as the “articles of association”), in a prudent and responsible manner, we conducted prior deliberation on relevant proposals before the ninth meeting of the eighth board of directors, and issued the following prior approval opinions based on independent judgment:
1、 Prior approval opinions on re employment of audit institutions in 2022
The company has communicated with us in advance about the proposed appointment of KPMG Huazhen Certified Public Accountants (special general partnership) (hereinafter referred to as “KPMG Huazhen”) as the audit institution in 2022. After verification, KPMG Huazhen has the qualification to audit securities and futures related businesses, has the ability to audit the company’s financial status, and can meet the requirements of the company’s financial audit. In the audit work in 2021, KPMG Huazhen scrupulously fulfilled its duties, followed the professional standards of independence, objectivity and impartiality, and successfully completed the audit of the company’s 2021 financial report. Agree to renew the appointment of KPMG Huazhen as the company’s audit institution in 2022 and submit this matter to the ninth meeting of the eighth board of directors for deliberation.
2、 Prior approval opinions on the prediction of daily connected transactions in 2022
We believe that the expected events of the company’s daily related party transactions in 2022 belong to the normal business scope of the company’s business activities and meet the needs of the company’s daily operation. The related party transactions are fair and reasonable, the price is fair, and do not damage the rights and interests of the company and the majority of shareholders. When the above matters are submitted to the board of directors for consideration, the related directors Mr. Yu Rong, Ms. Guo Meiling, Mr. Wang Xiaojun, Mr. Yang CE, Mr. Zhu Chao and Ms. Wu Tong need to avoid voting. We agree to submit this proposal to the 9th meeting of the 8th board of directors for deliberation.
Independent director of the company: Wang Hui, Shi Donghui, Zheng Xingjun, Wang Haitong April 14, 2002
